(Q39013030)

English

Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity.

scientific article published on 18 March 2014

Statements

Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit